Increased antimicrobial consumption following reimbursement reform in Turkey

Basit Öğe Kaydı
dc.authorid0000-0003-1514-1685en_US
dc.authorid0000-0002-4034-9202en_US
dc.contributor.authorKarabay, Oğuz
dc.contributor.authorHoşoğlu, Salih
dc.date.accessioned2021-06-23T19:25:51Z
dc.date.available2021-06-23T19:25:51Z
dc.date.issued2008
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractObjectives: This study examined antibiotic utilization patterns in Turkey between 2001 and 2006. Methods: A comprehensive collection and analysis of Turkish antibiotic data from 2001 to 2006 was conducted. The anatomical therapeutic chemical (ATC) classification and the defined daily dose (DDD) methodology were used to calculate antibiotic consumption. Data were presented as DDD/1000 inhabitant-days, and the relation between antimicrobial consumption and governmental reimbursement policy was evaluated. Results: Total utilization of antibiotics increased from 14.62 to 31.36 DDD/1000 inhabitant-days between 2001 and 2006. The largest increase took place after the implementation of social insurance reform (SIR) in 2005, as evidenced by the DDD ratio increasing 1.87-fold after SIR went into effect. The largest increase occurred in the prescription of penicillins, from 7.13 in 2001 to 14.09 in 2006. Conclusions: In Turkey, antibiotic consumption increased markedly in recent years, in a close relationship, to a new reimbursement policy following the implementation of the SIR, which facilitated the prescription and consumption of drugs compared with the earlier SIR conditions.en_US
dc.identifier.doi10.1093/jac/dkn055
dc.identifier.endpage1171en_US
dc.identifier.issn0305-7453
dc.identifier.issn1460-2091
dc.identifier.issue5en_US
dc.identifier.pmid18272511en_US
dc.identifier.scopus2-s2.0-42149087041en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1169en_US
dc.identifier.urihttps://doi.org/10.1093/jac/dkn055
dc.identifier.urihttps://hdl.handle.net/20.500.12491/6285
dc.identifier.volume61en_US
dc.identifier.wosWOS:000254955300033en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorKarabay, Oğuz
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofJournal Of Antimicrobial Chemotherapyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAntibiotic Policyen_US
dc.subjectAntibacterial Drug Screening Policyen_US
dc.subjectAntimicrobial Agentsen_US
dc.subjectAntimicrobial Resistance Surveillanceen_US
dc.titleIncreased antimicrobial consumption following reimbursement reform in Turkeyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
oguz-karabay.pdf
Boyut:
93.22 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin/Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu